Shelton Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Shelton Capital Management's HALO Position: Q2 2026 in Review
Shelton Capital Management reduced its Halozyme (HALO) stake by 3.8% in Q2 2026, selling an estimated $10.3K and leaving 3,807 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #546.
Shelton Capital Management first reported a position in HALO in Q4 2020 and has held it in 23 quarters since. The position peaked at $390K in Q4 2022. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Shelton Capital Management held 3,807 shares of Halozyme worth $298K as of Q2 2026.
- Shelton Capital Management sold 151 Halozyme shares in Q2 2026, an estimated $10.3K.
- Halozyme made up 0.01% of Shelton Capital Management's portfolio in Q2 2026, its #546 holding.
- Shelton Capital Management first reported a position in Halozyme in Q4 2020 and has held it in 23 quarters since.
- Shelton Capital Management's Halozyme position peaked at $390K in Q4 2022.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.